First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q4 2024 (December 31)21holders −1
2new positions
4sold out
$27.01avg. 13F price*
At the end of Q4 2024, 21 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, down 1 from Q3 2024. 2 opened new positions and 4 sold out. The largest holders were LPL Financial LLC ($1.5M), Susquehanna International Group, LLP ($1.3M) and Goldman Sachs Group Inc. ($470K).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $416K |
| Exits | 4 | $1.2M |
All 13F filers, Q3 2024 → Q4 2024: 29,875 shares bought and 71,457 shares sold, net −41,582 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| LPL Financial LLC | 0.00% | Add +9.3% | 55,876 | $1.5M |
| Susquehanna International Group, LLP | 0.00% | Add +9.8% | 47,518 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -63.6% | 17,425 | $470K |
| Envestnet Asset Management Inc. | 0.00% | Add +17.0% | 16,403 | $442K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +13.0% | 14,173 | $382K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 13,904 | $375K |
| WMG Financial Advisors, LLC | 0.15% | Reduce -0.7% | 13,293 | $358K |
| Debussy Capital Management LP | 0.04% | Add +15.6% | 8,677 | $243K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -0.1% | 8,257 | $223K |
| Morgan Stanley | 0.00% | Reduce -0.0% | 5,941 | $160K |
| Bank of Montreal | 0.00% | No change | 4,888 | $132K |
| Osaic Holdings, Inc. | 0.00% | Add +11.4% | 2,450 | $66K |
| UBS Group AG | 0.00% | New | 1,504 | $41K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $23K |
| Larson Financial Group LLC | 0.00% | No change | 713 | $19K |
| Continuum Advisory, LLC | 0.00% | No change | 650 | $18K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $16K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $12K |
| IFP Advisors, Inc | 0.00% | No change | 307 | $8K |
| Lanark Financial, Inc. | 0.01% | — | 5 | $147 |
| Wells Fargo & Company | 0.00% | Add +0.0% | 1 | $30 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.